Plain-English translation of NCT07409506 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is looking at the role family caregivers play in caring for people with Alzheimer's disease. Researchers want to understand how much informal care (help from family and friends) patients need as their condition progresses, and how this changes depending on the severity of their memory loss, their independence level, and other health problems they may have.
In France and across the world, family caregivers provide enormous amounts of unpaid care for people with Alzheimer's disease—in fact, this informal care is worth billions of euros each year. Understanding exactly what caregivers do and how their role changes as the disease progresses will help governments and healthcare systems make better decisions about where to direct resources and support.
You likely qualify if…
You likely don't qualify if…
If you join this study, you and your caregiver would be asked to share information about your daily life, your care needs, and the help you receive—this may happen through interviews, questionnaires, or by allowing researchers to review your medical records. The study does not involve taking a new medication or undergoing new medical procedures; instead, it focuses on gathering detailed information about the caregiving support you already receive to help researchers understand patterns across different stages of Alzheimer's disease.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
France